fda bpc-157 status 2026 BPC 157 Banned: Key Facts on the Latest Decision BPC-157 FDA Status 2026: What
Description
Dosing is typically 250-500mcg twice daily for injectable, or 500-1,000mcg daily for oral
Self-reported dose per injection Median bucket: 0.20.4 mg Most common: 0.20.4 mg Reports span 0.1 to 5 mg (open-ended top bucket) Anonymized self-reports from PeptIQ users not prescribing guidance
Its status as a research-only chemical automatically places it on the prohibited list
Peptides often work by saturating receptors or triggering a systemic response, which is less dependent on the user's mass
